Wade G W & Inc Becton Dickinson & CO Transaction History

Wade G W & Inc

$3.08 Billion
Q4 2023

A detailed history of Wade G W & Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Wade G W & Inc holds 2,069 shares of BDX stock, worth $471,980. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,069

Previous 2,072 0.14%

Holding current value

$471,980

Previous $536,000 5.97%

% of portfolio

0.02%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$232.24 - $267.23 $696 - $801	-3 Reduced 0.14%	2,069 $504,000
Q2 2023 Aug 10, 2023	BUY	$238.39 - $265.32 $238 - $265	1 Added 0.05%	2,072 $547,000
Q1 2023 May 09, 2023	SELL	$229.71 - $259.35 $9,647 - $10,892	-42 Reduced 1.99%	2,071 $513,000
Q4 2022 Feb 10, 2023	SELL	$218.29 - $256.91 $62,430 - $73,476	-286 Reduced 11.92%	2,113 $537,000
Q3 2022 Nov 10, 2022	SELL	$51.03 - $264.23 $6,531 - $33,821	-128 Reduced 5.07%	2,399 $535,000
Q2 2022 Aug 09, 2022	BUY	$234.74 - $275.42 $8,215 - $9,639	35 Added 1.4%	2,527 $623,000
Q1 2022 May 10, 2022	SELL	$243.64 - $270.48 $17,785 - $19,745	-73 Reduced 2.85%	2,492 $663,000
Q4 2021 Feb 09, 2022	BUY	$230.08 - $250.94 $256,539 - $279,798	1,115 Added 76.9%	2,565 $645,000
Q3 2021 Nov 03, 2021	BUY	$232.72 - $256.47 $17,686 - $19,491	76 Added 5.53%	1,450 $356,000
Q2 2021 Aug 12, 2021	SELL	$232.65 - $254.58 $43,738 - $47,861	-188 Reduced 12.04%	1,374 $334,000
Q1 2021 May 05, 2021	SELL	$232.09 - $256.88 $89,818 - $99,412	-387 Reduced 19.86%	1,562 $380,000
Q4 2020 Feb 03, 2021	BUY	$221.92 - $245.94 $432,522 - $479,337	1,949 New	1,949 $488,000

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.1B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wade G W & Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wade G W & Inc with notifications on news.

Account